Mo. Apr 22nd, 2024

The report titled Tuberculin Market: Opportunity Analysis and Future Assessment 2022-2030” freshly published by Reports & Insights has the primary objective to offer its clients outright in-depth and meticulous information about the respective market along with the thorough knowledge of the statistics oriented in the direction of development of the respective market. For a clearer picture of the readers, the report also offers comprehensive know-how of the market, conceptual structure, and prevailing trends of the market together with the detailed textual and graphical representation. In addition, the report also cites comprehensively about the key players competing in the market for the unfluctuating intrigue of its readers.

The global tuberculin market in 2022 is estimated for more than US$ 231.9 Mn and expected to reach a value of US$ 359.2 Mn by 2030 with a significant CAGR of 5.6%.

Access Sample Copy of “Tuberculin Market Report”:

Tuberculin Introduction

Tuberculin is a combination of proteins used in the diagnosis of tuberculosis. Tuberculin is used to perform a tuberculin skin test and is recommended only for high-risk tuberculosis patients. Tuberculin was discovered in 1980 and originally it was developed as a remedy for tuberculosis but was found to be ineffective.

Tuberculin test is referred to as a Mantoux test. Patients with active tuberculosis are indicated as tuberculin positive and upon intradermals injection of tuberculin develop hypersensitivity reaction at the site of injection. Tuberculin is obtained from a human strain of Mycobacterium tuberculosis grown on a protein-free synthetic medium and buffered with potassium and sodium phosphates.

Tuberculin Market Dynamics

Growing incidence of infectious diseases including tuberculosis is the first and foremost factor driving the growth of tuberculin market. According to the Center for Disease Control and Prevention (CDC), one-third of the global population is infected with tuberculosis and there were 1.7 Bn tuberculosis-related deaths globally in 2017.

In U.S. 9,272 new cases of tuberculosis were reported in 2017. Commonly used brands of tuberculin include Aplisol and Tubersol. In the recent past, there has been a shortage of tuberculin due to the economic slowdown in several countries in Europe. However, the tuberculin market is gaining traction over the forecast period after the restoration of the economy.

View Complete TOC and Figures & Graphs of Tuberculin Market Industry Report –

Tuberculin Market Segmentation

The global tuberculin market is segmented on the basis of product type, end-user, and region. On the basis of product type, the global tuberculin market is segmented into:

Purified Protein Derivative S (PPD S)

Purified Protein Derivative RT23 (PPD RT23)


By end-user, global tuberculin market is segmented into:


Diagnostic Centers

Others (e.g. government programs, etc)

On the basis of region, the global tuberculin market is segmented into six regions namely:

North America

Latin America

Asia Pacific


Middle East


Tuberculin Market Key Players

Global tuberculin market is mainly dominated by:

Sanofi SA


Par Pharmaceuticals

Japan BCG

Sanroad Biological


To view Top Players, Segmentation and other Statistics of Tuberculin Industry, Get Sample Report: @

About Reports and Insights:

Reports and Insights is one of the leading market research company which offers syndicate and consulting research around the globe. At Reports and Insights we adhere to the client needs and regularly ponder to bring out more valuable and real outcomes for our customers. We are equipped with strategically enhanced group of researchers and analysts that redefines and stabilizes the business polarity in different categorical dimensions of the market.

Contact Us:

Neil Jonathan

1820 Avenue M, Brooklyn

NY 11230, United States

+1-(718) 312-8686

Find Us on Linkedin:

View Latest Market Updates at:

Pressemitteilung teilen:
Devid Won

Von Devid Won

Schreibe einen Kommentar